Frequency and determinants of thyroid autoimmunity in Ghanaian type 2 diabetes patients: a case-control study
BMC Endocrine Disorders - 2017
Tóm tắt
The link between type 1 diabetes and thyroid autoimmunity is well described. The same cannot be said for type 2 diabetes where results have been mixed so far. We investigated the prevalence and determinants of thyroid autoimmunity among Ghanaian type 2 diabetes patients. This was a case-control study involving 302 type 2 diabetes patients and 310 non - diabetic controls aged 40–80 years. Anthropometric and blood pressure measurements were obtained. Fasting samples were analyzed for glucose, thyroid function, and antibodies to thyroglobulin and thyroid peroxidase. The prevalence of thyroid autoimmunity was significantly higher among T2DM subjects (12.2% vs. 3.9%, p = 0.0004). Among T2DM subjects, 44 (14.7%) tested positive for TPOAb, 5 (1.7%) tested positive for TGAb and 15 (5.0%) tested positive for both autoantibodies. Females T2DM subjects showed a 3-fold increased risk of thyroid autoimmunity compared to males (OR:3.16, p =0.004), T2DM subjects with hyperthyroidism had a 41% increased risk of thyroid autoimmunity (OR: 1.41, p < 0.001), sub-clinical hyperthyroidism increased the risk of thyroid autoimmunity by 2 fold, (OR:2.19, p < 0.001), subclinical hypothyroidism increased the risk of autoimmunity by 4-fold, (OR:3.57 95% p < 0.0001), and hypothyroidism was associated with a 61% increased risk of thyroid autoimmunity (OR: 1.61,1.35–2.23). Dyslipidaemia was associated with a 44% increased risk of thyroid autoimmunity (OR: 1.44, p = 0.01) and a percentage increase in HbA1c was associated with 46% increased risk of thyroid autoimmunity (OR:1.46, p < 0.0001). We observed a high prevalence of thyroid autoimmunity in Ghanaian T2DM subjects compared to the general population. Thyroid autoimmunity in T2DM subjects was significantly associated with female gender, thyroid dysfunction, dyslipidaemia and poor glycemic control.
Từ khóa
Tài liệu tham khảo
Sathish R, Mohan V. Diabetes and Thyroid diseases- a review. Int J Diab Dev Ctries. 2003;23(4):120–3.
Al-Wazzan HT, Daban AH, Askar RA. El- Shazly MK. Prevalence and associated factors of thyroid dysfunction among type 2 diabetic patients in Kuwait. Alex Bull. 2010;46(2):141–8.
Papazafiropoulou A, Sotiropoulos A, Kokolaki A, Kodora M, Stamatai P, Stavros P. Prevalence of thyroid dysfunction amongst Greek Type 2 Diabetes Mellitus patients attending an outpatient Clinic. J Clin Med Res. 2010;2(2):75–8.
Akbar DH, Ahmed MM, Al-Mughales J. Thyroid dysfunction and thyroid autoimmunity in Saudi type 2 diabetics. ACTA Diabetologia. 2006;43(1):14–8.
Ghazali SM, Abbiyesuku FM. Thyroid dysfunction in type 2 diabetics seen at the University College Hospital, Ibadan, Nigeria. Niger J Physiol Sci. 2010;25(2):173–9.
Radaideh AR, Nusier MK, Amari FL, Bateiha AE, El-Khateeb MS, Naser AS, Ajlouni KM. Thyroid dysfunction in patients with type 2 diabetes mellitus in Jordan. Saudi Med J. 2004;25(8):1046–50.
Perros P, McCrimmon RJ, Shaw G, Frier BM. Frequency of thyroid dysfunction in diabetic patients: value of annual screening. Diabet Med. 1995;12:622–7.
Freely J, Isles TE. Screening for thyroid dysfunction in diabetics. Br Med J. 1979;1(6179):1678.
Tunbridge WMG, Everd DC, Hall R, Appleton D, Brewis M, Clark F. The spectrum of thyroid disease in the community: The Wickham survey. Clin Endocrinol. 1997;19:481–93.
Weetman AP. Diseases associated with thyroid autoimmunity: an explanation for the expanding spectrum. Clin Endocrinol(oxf). 2011;74:411–8.
Kahaly GJ, Dienes HP, Beyer J, Hommel G. Iodide induces thyroid autoimmunity patients with endemic goiter: A randomized, double-blind, placebo-controlled trial. Eur J Endocrinol. 1998;139:290–70.
Hetzel BS. Iodine deficiency disorders (IDD) and their eradication. Lancet. 1983;2:1126–9.
World Health Organization. Iodine Status Worldwide: WHO Global Database on Iodine Deficiency. Geneva: WHO; 2004. p. 1–58. http://www.who.int/nutrition/publications/micronutrients/FNBvol29N3sep08.pdf?ua=1.
Donckier JE. Endocrine diseases and Diabetes. In: Pickup JC, Williams G, editors. Textbook of Diabetes mellitus. Chichester: Black Well Publishing Company; 2003. p. 27.1–27.25.
Radetti G, Paganini C, Gentili L, Bernasconi S, Betterle C, Borkenstein M, Cvijovic K, Kadrnka-Lovrencic M, Krzisnik C, Battelino T, et al. Frequency of Hashimoto’s thyroiditis in children with type 1 diabetes mellitus. Acta Diabetol. 1995;32:121–4.
Umpierrez GE, Latif KA, Murphy MB, Lambeth HC, Stentz F, Bush A, Kitabchi AE. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care. 2003;26(4):1181–5.
World Health Organisation. Obesity: Prevention and managing the global epidemic. Report of a WHO consultation. Geneva: WHO Technical Report Series 894; 2000.
World Health Organisation. Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus. 2007. Available from www.who.int/diabetes/publications/en/. Accessed 18 June 2015.
Chalmers J, McMahon S, Mancia G, Whitwort J, Beilin L, Hansson L, et al. 1999 World Health Organisation-International Society of Hypertension Guidelines for treatment of hypertension. Guideline subcommittee of the World Health Organisation. Clin Exp Hypertens. 1999;21(5–6):1009–60.
Wannamethee SG, Shaper AG, Perry IJ. British Regional Heart Study: Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 2001;204(9):1590–5.
Shaper AG, Wanathee G, Walker M. Alcohol and Mortality: explaining the U shaped Curve. Lancet. 1988;2:1268–73.
Afkhami-Ardekani M, Rashidi M, Shojaoddeny- Ardekani A. Evaluation of thyroid autoantibody in type 2 diabetes. IJDO. 2009;1(1):1–4.
Cardoso C, Ohwovoriole AE, Kuku SF. A study of thyroid function and prevalence of thyroid autoantibodies in an African diabetic population. J Diabetes Complications. 1995;9(1):37–41.
Jellinger PS, Smith DA, Mehta AE, Ganda O, Handelsman Y, Rodbard HW, et al. American association of clinical endocrinologists’ guidelines for management of Dyslipidemia and prevention of atherosclerosis. Endocr Pract. 2012;18 Suppl 1:1–78.
Yasmin T, Ghafoor F, Malik T. S RN, Khan AU. The pattern of thyroid autoimmunity in type 1 and type 2 diabetics. J Coll Physicians Surg Pak. 2006;16(12):751–4.
Konstantinos, Xanthippi T, Evangelos P, Triantafyllos D, Anna G, Pantelis Z et al. Thyroid Autoimmunity in the Context of Type 2 Diabetes Mellitus: Implications for Vitamin D. Int Journal of Endocrinology 2015; ol. 2015, Article ID 710363, 2015. doi:10.1155/2015/710363.
Okosieme OE, Taylor RC, Ohwoviorole AE, Parkes AB, Lazarus JH. Prevalence Of thyroid autoantibodies in Nigeria Patients. QJM. 2007;100(2):107–12.
Gunasekara P, Hettiarachchi M, Liyanage C, Lekamwasam S. Effects of zinc and multimineral vitamin supplementation on glycaemic and lipid control in adult diabetes. Diabetes Metab Syndr Obes. 2011;4:53–60.
Lang TJ. Estrogen as an immunomodulatory. Clin Immunol. 2004;113:224–30.
Fairweather D, Frisando-Kiss S, Rose NR. Sex differences in Autoimmune diseases from pathological perspective. Am J Pathol. 2008;173(3):600–9.
Pearce EN, Farwell AP, Braverman LE. Thyroiditis. N Eng J Med. 2003;348:2646.
Trbojević B, Djurica S. Diagnosis of autoimmune thyroid disease. Srp Arh Celok Lek. 2005;133 Suppl 1:25–33.
Spencer CA. Challenges of serum thyroglobulin (Tg) measurement in the presence of Tg autoantibodies. J Clin Endocrinol Metab. 2004;89:3702–4.
Chubb SAP, Davis WA, Inman Z, Davis TME. Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: The Fremantle Diabetes Study. Clin Endocrinol. 2005;62:480–6.
Hage M, Zantout MSM, Azar ST. Thyroid disorder and diabetes mellitus. J Thyroid Res. 2011;2011:439463.
Chehade JM, Gladysz M, Mooradian AD. Dyslipidaemia in type 2 diabetes: Prevalence, pathophysiology, and management. Drugs. 2013;73(4):327–39.
Primo ME, Niepomniszcze H, Poskus E, Sala MS, Guaita SS, Sica MP, Villalba A, Cardoso A, Bruno OD. Frequency of pancreatic beta-cell autoimmunity markers in patients with autoimmune thyroid disease. Medicina (B Aires). 2008;68(1):37–42.